erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world..may 17, 2018, 10:42am edt...jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..